Autopsy report · NCT01167192
Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer
Cause of deathNo reason given
Life of this trial
- Registered 7 months before it started.
- Ran for about 5 years 7 months before it stopped.
- 10 participants enrolled.
- Results were posted on the registry 1 month after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Washington University School of Medicine
- Sponsor type
- University, hospital or other
- Conditions
- Breast Neoplasms
- Interventions
- Cisplatin; Carboplatin; Radiation therapy; Mastectomy (recommended but not mandatory)
- Participants
- 10
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.